Advertisement
Screener

CELCUITY INC. (CELC) Stock-Based Compensation

2.8 / 5 stars · 68/120 Roast Me

CELCUITY INC. Stock-Based Compensation

CELCUITY INC. (CELC) reported Stock-Based Compensation of $6.90 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2026-08-13

  • CELCUITY INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $6.90M, a 155.33% increase year-over-year.
  • CELCUITY INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $5.33M, a 117.88% increase year-over-year.
  • CELCUITY INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $9.46M, a 308.47% increase year-over-year.
  • CELCUITY INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $6.78M, a 251.06% increase year-over-year.
  • CELCUITY INC. share-based payment arrangement, noncash expense for fiscal 2025 was $21.38M, a 206.00% increase from fiscal 2024.
  • CELCUITY INC. share-based payment arrangement, noncash expense for fiscal 2024 was $6.99M, a 42.57% increase from fiscal 2023.
  • CELCUITY INC. share-based payment arrangement, noncash expense for fiscal 2023 was $4.90M, a 5.68% increase from fiscal 2022.
  • CELCUITY INC. share-based payment arrangement, noncash expense for fiscal 2022 was $4.64M, a 77.71% increase from fiscal 2021.
Period endShare-based Payment Arrangement, Noncash Expense 3 monthShare-based Payment Arrangement, Noncash Expense 3 month as first filedShare-based Payment Arrangement, Noncash Expense 6 monthShare-based Payment Arrangement, Noncash Expense 6 month as first filedShare-based Payment Arrangement, Noncash Expense 9 monthShare-based Payment Arrangement, Noncash Expense 9 month as first filedShare-based Payment Arrangement, Noncash Expense 12 monthShare-based Payment Arrangement, Noncash Expense 12 month as first filed
2026-06-30$6.90M
10-Q · filed 2026-08-13
$12.23M
10-Q · filed 2026-08-13
$21.68M
derived: sum of 3 quarters · filed 2026-08-13
$28.46M
derived: sum of 4 quarters · filed 2026-08-13
2026-03-31$5.33M
10-Q · filed 2026-05-14
$14.78M
derived: sum of 2 quarters · filed 2026-05-14
$21.56M
derived: sum of 3 quarters · filed 2026-05-14
$24.26M
derived: sum of 4 quarters · filed 2026-08-13
2025-12-31$9.46M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26
$16.23M
derived: sum of 2 quarters · filed 2026-03-26
$18.94M
derived: sum of 3 quarters · filed 2026-08-13
$21.38M
10-K · filed 2026-03-26
2025-09-30$6.78M
10-Q · filed 2025-11-13
$9.48M
derived: sum of 2 quarters · filed 2026-08-13
$11.93M
10-Q · filed 2025-11-13
$14.24M
derived: sum of 4 quarters · filed 2026-08-13
2025-06-30$2.70M
10-Q · filed 2026-08-13
$5.15M
10-Q · filed 2026-08-13
$7.46M
derived: sum of 3 quarters · filed 2026-08-13
$9.39M
derived: sum of 4 quarters · filed 2026-08-13
2025-03-31$2.44M
10-Q · filed 2026-05-14
$4.76M
derived: sum of 2 quarters · filed 2026-05-14
$6.69M
derived: sum of 3 quarters · filed 2026-05-14
$8.10M
derived: sum of 4 quarters · filed 2026-05-14
2024-12-31$2.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26
$4.25M
derived: sum of 2 quarters · filed 2026-03-26
$5.66M
derived: sum of 3 quarters · filed 2026-03-26
$6.99M
10-K · filed 2026-03-26
$6.99M
10-K · filed 2025-03-31
2024-09-30$1.93M
10-Q · filed 2025-11-13
$1.93M
10-Q · filed 2024-11-14
$3.34M
derived: sum of 2 quarters · filed 2025-11-13
$4.67M
10-Q · filed 2025-11-13
$4.67M
10-Q · filed 2024-11-14
$5.92M
derived: sum of 4 quarters · filed 2025-11-13
2024-06-30$1.41M
10-Q · filed 2025-08-14
$1.41M
10-Q · filed 2024-08-14
$2.74M
10-Q · filed 2025-08-14
$2.74M
10-Q · filed 2024-08-14
$3.98M
derived: sum of 3 quarters · filed 2025-08-14
$5.09M
derived: sum of 4 quarters · filed 2025-08-14
2024-03-31$1.33M
10-Q · filed 2025-05-15
$1.33M
10-Q · filed 2024-05-15
$2.57M
derived: sum of 2 quarters · filed 2025-05-15
$3.68M
derived: sum of 3 quarters · filed 2025-05-15
$4.96M
derived: sum of 4 quarters · filed 2025-05-15
2023-12-31$1.24M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31
$2.35M
derived: sum of 2 quarters · filed 2025-03-31
$3.63M
derived: sum of 3 quarters · filed 2025-03-31
$4.90M
10-K · filed 2025-03-31
2023-09-30$1.11M
10-Q · filed 2024-11-14
$2.39M
derived: sum of 2 quarters · filed 2024-11-14
$3.66M
10-Q · filed 2024-11-14
$4.80M
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30$1.28M
10-Q · filed 2024-08-14
$2.55M
10-Q · filed 2024-08-14
$3.69M
derived: sum of 3 quarters · filed 2024-08-14
$4.91M
derived: sum of 4 quarters · filed 2024-08-14
2023-03-31$1.27M
10-Q · filed 2024-05-15
$2.41M
derived: sum of 2 quarters · filed 2024-05-15
$3.64M
derived: sum of 3 quarters · filed 2024-05-15
$5.16M
derived: sum of 4 quarters · filed 2024-05-15
2022-12-31$1.14M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27
$2.36M
derived: sum of 2 quarters · filed 2024-03-27
$3.88M
derived: sum of 3 quarters · filed 2024-03-27
$4.64M
10-K · filed 2024-03-27
2022-09-30$1.22M
10-Q · filed 2023-11-13
$2.74M
derived: sum of 2 quarters · filed 2023-11-13
$3.50M
10-Q · filed 2023-11-13
$4.42M
derived: sum of 4 quarters · filed 2023-11-13
2022-06-30$1.52M
10-Q · filed 2023-08-11
$2.28M
10-Q · filed 2023-08-11
$3.20M
derived: sum of 3 quarters · filed 2023-08-11
$3.90M
derived: sum of 4 quarters · filed 2023-08-11
2022-03-31$756.27K
10-Q · filed 2023-05-15
$1.68M
derived: sum of 2 quarters · filed 2023-05-15
$2.38M
derived: sum of 3 quarters · filed 2023-05-15
$2.92M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31$920.60K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23
$1.62M
derived: sum of 2 quarters · filed 2023-03-23
$2.16M
derived: sum of 3 quarters · filed 2023-03-23
$2.61M
10-K · filed 2023-03-23
2021-09-30$699.92K
10-Q · filed 2022-11-10
$1.24M
derived: sum of 2 quarters · filed 2022-11-10
$1.69M
10-Q · filed 2022-11-10
$2.12M
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30$540.32K
10-Q · filed 2022-08-12
$989.41K
10-Q · filed 2022-08-12
$1.42M
derived: sum of 3 quarters · filed 2022-08-12
$1.87M
derived: sum of 4 quarters · filed 2022-08-12
2021-03-31$449.10K
10-Q · filed 2022-05-16
$876.19K
derived: sum of 2 quarters · filed 2022-05-16
$1.33M
derived: sum of 3 quarters · filed 2022-05-16
$1.75M
derived: sum of 4 quarters · filed 2022-05-16
2020-12-31$427.09K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23
$876.04K
derived: sum of 2 quarters · filed 2022-03-23
$1.30M
derived: sum of 3 quarters · filed 2022-03-23
$1.76M
10-K · filed 2022-03-23
2020-09-30$448.95K
10-Q · filed 2021-11-09
$872.14K
derived: sum of 2 quarters · filed 2021-11-09
$1.34M
10-Q · filed 2021-11-09
$1.70M
derived: sum of 4 quarters · filed 2021-11-09
2020-06-30$423.19K
10-Q · filed 2021-08-11
$887.84K
10-Q · filed 2021-08-11
$1.25M
derived: sum of 3 quarters · filed 2021-08-11
$1.55M
derived: sum of 4 quarters · filed 2021-08-11
2020-03-31$464.65K
10-Q · filed 2021-05-10
$825.50K
derived: sum of 2 quarters · filed 2021-05-10
$1.13M
derived: sum of 3 quarters · filed 2021-05-10
$1.32M
derived: sum of 4 quarters · filed 2021-05-10
2019-12-31$360.86K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16
$664.10K
derived: sum of 2 quarters · filed 2021-02-16
$856.35K
derived: sum of 3 quarters · filed 2021-02-16
$1.04M
10-K · filed 2021-02-16
2019-09-30$303.24K
10-Q · filed 2020-11-09
$303.24K
10-Q · filed 2019-11-07
$495.49K
derived: sum of 2 quarters · filed 2020-11-09
$680.13K
10-Q · filed 2020-11-09
$935.71K
derived: sum of 4 quarters · filed 2020-11-09
2019-06-30$192.25K
10-Q/A · filed 2020-08-11
$376.89K
10-Q/A · filed 2020-08-11
$632.47K
derived: sum of 3 quarters · filed 2020-08-11
$932.74K
derived: sum of 4 quarters · filed 2020-08-11
2019-03-31$184.65K
10-Q · filed 2020-05-07
$440.22K
derived: sum of 2 quarters · filed 2020-05-07
$740.50K
derived: sum of 3 quarters · filed 2020-05-07
$1.02M
derived: sum of 4 quarters · filed 2020-05-07
2018-12-31$255.58K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13
$555.85K
derived: sum of 2 quarters · filed 2020-03-13
$832.14K
derived: sum of 3 quarters · filed 2020-03-13
$1.17M
10-K · filed 2020-03-13
2018-09-30$300.28K
10-Q · filed 2019-11-07
$576.56K
derived: sum of 2 quarters · filed 2019-11-07
$913.04K
10-Q · filed 2019-11-07
$1.23M
derived: sum of 4 quarters · filed 2019-11-07
2018-06-30$276.28K
10-Q · filed 2019-08-08
$612.76K
10-Q · filed 2019-08-08
$926.05K
derived: sum of 3 quarters · filed 2019-08-08
$1.06M
derived: sum of 4 quarters · filed 2019-08-08
2018-03-31$336.48K
10-Q · filed 2019-05-07
$649.77K
derived: sum of 2 quarters · filed 2019-05-07
$788.05K
derived: sum of 3 quarters · filed 2019-05-07
$1.11M
derived: sum of 4 quarters · filed 2019-05-07
2017-12-31$313.29K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01
$451.57K
derived: sum of 2 quarters · filed 2019-03-01
$778.12K
derived: sum of 3 quarters · filed 2019-03-01
$874.39K
10-K · filed 2019-03-01
2017-09-30$138.28K
10-Q · filed 2018-11-13
$464.83K
derived: sum of 2 quarters · filed 2018-11-13
$561.10K
10-Q · filed 2018-11-13
$638.83K
derived: sum of 4 quarters · filed 2018-11-13
2017-06-30$326.55K
10-Q · filed 2018-08-09
$422.82K
10-Q · filed 2018-08-09
$500.55K
derived: sum of 3 quarters · filed 2018-08-09
$573.82K
derived: sum of 4 quarters · filed 2018-08-09
2017-03-31$96.27K
10-Q · filed 2018-05-14
$174.00K
derived: sum of 2 quarters · filed 2018-05-14
$247.27K
derived: sum of 3 quarters · filed 2018-05-14
2016-12-31$77.73K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15
$151.00K
derived: sum of 2 quarters · filed 2018-03-15
$187.31K
10-K · filed 2018-03-15
2016-09-30$73.28K
10-Q · filed 2017-12-01
$109.58K
10-Q · filed 2017-12-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
VERACYTE, INC. (VCYT)United States$3.904B41.21
CareDx, Inc. (CDNA)United States$3.174B13.21
GRAIL, Inc. (GRAL)United States$5.591B-7.78
RadNet, Inc. (RDNT)United States$5.611B-229.65
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
Personalis, Inc. (PSNL)United States$1.769B-13.30
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
BIODESIX INC (BDSX)United States$0.312B